Behandling af centralnervesystemlymfom efter transplantation med monoklonalt antistof og ganciclovir

Ugeskrift for Laeger

Volumn 172, Issue 42, 2010, Pages 2907-2908

  Hansen, Per Boye ^a   Al Farra, Gina ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ANTIVIRUS AGENT; DRUG DERIVATIVE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PREDNISOLONE; RITUXIMAB; VALGANCICLOVIR;

ADULT; ARTICLE; BRAIN TUMOR; CASE REPORT; DRUG COMBINATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; LARGE CELL LYMPHOMA; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; DRUG THERAPY, COMBINATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GANCICLOVIR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDNISOLONE; TREATMENT OUTCOME;

EID: 78149396935     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med 2005;56:29-44.
2. Choquet S, Leblond V, Herbrecht R, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: result of a prospective multicenter phase 2 study. Blood 2006;107:3053-7.
3. Brunstein CG, Weisdorf DJ, DeFor T, et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006;108:2874-80.
4. Kordelas L, Trenschel R, Koldehoff M, et al. Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab. Onkologie 2008;31:691-3.
5. Hänel M, Fiedler F, Thorns C. Anti-CD20 monoclonal antibody (rituximab) and cidofovir as successful treatment of and EBV-associated lymphoma with CNS involvement. Onkologie 2001;24:491-4.